To compare obstetric outcome for singletons born after frozen embryo transfer (FET) in stimulated vs natural cycles. Comparison was also made for FET vs fresh IVF and for FET vs spontaneous conception (SC). STUDY DESIGN: A population-based retrospective registry study including all singletons born after FET in Sweden from 2005 to 2015. The IVF register was crosslinked with the Medical Birth Register and the Prescribed Drug Register. Singletons after stimulated FET were compared with singletons after natural FET. All FET singletons were also compared with fresh IVF and SC singletons. Main outcomes were preterm birth (PTB) (<37 w), low birth weight (LBW) (<2500 g), macrosomia (>4500 g), placenta previa, placental abruption, hypertensive disorders in pregnancy (HDP) and postpartum hemorrhage (PPH) (>1000 ml). Crude and adjusted odds ratio (AOR) with 95% confidence interval (CI) were calculated. Adjustment was made for maternal age, parity, year of birth of child, smoking, maternal education, years of infertility and child'sex and for deliveries following IVF/ICSI for number of gestational sacs, culture duration and freezing method. RESULTS: 9726 singletons were born after FET (stimulated n¼3429, natural n¼6297), 24 365 after fresh IVF and 1 127 566 after SC. Stimulated FET was associated with a higher risk of macrosomia AOR 1.31 (1.08-1.60), HDP AOR 1.36 (1.15-1.62) and PPH AOR 1.67 (1.44- (1.09-1.31), placenta previa AOR 1.76 (1.40-2.20) and PPH AOR 1.74 (1.61-1.88) when compared to SC. CONCLUSION: Pregnancies after FET in natural vs stimulated cycles have a more favourable outcome with lower rates of macrosomia, HDP and PPH. This is important considering the new policy of freeze all cycles in IVF. Further, the results give no credit to the hypothesis that the lower rates of PTB and LBW noticed for FET in comparison to fresh IVF is due to the lack of hormone stimulation in natural FET.
(1.09-1.31), placenta previa AOR 1.76 (1.40-2.20) and PPH AOR 1.74 (1.61-1.88) when compared to SC. CONCLUSION: Pregnancies after FET in natural vs stimulated cycles have a more favourable outcome with lower rates of macrosomia, HDP and PPH. This is important considering the new policy of freeze all cycles in IVF. Further, the results give no credit to the hypothesis that the lower rates of PTB and LBW noticed for FET in comparison to fresh IVF is due to the lack of hormone stimulation in natural FET. th week, 540 singleton pregnancies with BMI!25 were enrolled in a prospective, open-label, RCT. Forty-one women refused to participate and the remnants were randomly assigned to customized diet (CUSTOM, n¼245; low glycemic index, 1800 Kcal/day + 30 minutes walking 4 times/week) or generic lifestyle advices (STANDARD CARE, SC, n¼244). In the CUSTOM group a dietician defined a grammar, ethnic-specific diet for each woman while SC group received a booklet with counselling of a prudent diet and Physical activity, according to Italian guidelines. Follow-up till the 36th week was the same for both groups, with gynecologist and dietitian both attendant. The main outcome was the rate of large for gestational age babies (LGA). Body composition was also measured with bioimpedance analysis.
RESULTS:
The socio-demographic features were similar among groups. Eightysix women were lost to follow-up, leaving 403 women for the analysis (CUSTOM¼206, SC¼197). Both the LGA and birthweight centile were lower in the CUSTOM group, while small for gestational age (SGA) and other outcomes were equally distributed (Table 1 ). Gestational Weight Gain was similar in both arms. Moreover, fat mass increase CUSTOM (BMI 35:3.9AE3.8 vs BMI!35:1.8AE3.5; p¼0.004) was lower compared to SC (BMI 35: 2.7AE6.8 vs BMI!35: 2.9AE4.7 Kg, p¼0.078). No differences in mode of delivery and other maternal/neonatal outcomes were found in the subgroup of women with BMI !35 (table 2) . CONCLUSION: A customized low-glycemic index, caloric-restricted diet associated to a constant physical activity reduced the rate of LGA infants without affecting SGA. This was particularly evident in obesity class II and III. A consultant dietician seems helpful to improve perinatal outcomes in obese women.
161 The impact of class III obesity on maternal and neonatal outcomes in preeclamptic patients 
OBJECTIVE:
The rate of obesity is increasing in women of reproductive age, and obesity is a major risk factor for preeclampsia. Our objective was to compare maternal and neonatal morbidity and mortality in preeclamptic patients between those with a BMI <40 and a BMI ! 40 (class III obesity). STUDY DESIGN: We conducted a secondary analysis of a multicenter prospective cohort study (PE Triage by Rapid Assay-PETRA trial). The study's primary objective was to validate placental growth factor as a biomarker for preeclampsia. Pregnant women at 20 0/7 to 40 0/7
weeks gestation who presented with signs or symptoms of preeclampsia (PE) were enrolled at 24 centers in the United States and Canada. The diagnosis of preeclampsia and other pregnancy complications were subsequently formulized by an adjudication group using standardized diagnostic criteria. Primary outcome was a composite neonatal morbidity (CNM) comprised of IVH (grade 3-4), NEC, BPD and perinatal death. Secondary outcomes were the components of CNM; small for gestational age (SGA) and gestational age at delivery (GA at del.) as well as maternal morbidity: abruption, renal failure, pulmonary edema, HELLP and eclampsia. Data were analyzed with the use of chi-square test and ANOVA as appropriate. RESULTS: 701 women with preeclampsia were evaluated: 585 (83%) had a BMI < 40 and 116 (17%) had a BMI ! 40. Baseline characteristics were different between groups regarding chronic
